Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 2, 2005
Role of 5'-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatmentConnie Brouwer, Trude M Vogels-Mentink, Jenneke J Keizer-Garritsen, et al.
Therapeutic Drug Monitoring|January 23, 2026
Tailoring Eculizumab Treatment: Evaluation of Model-Informed Precision Dosing for Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic SyndromeAstrid Heida, Mendy Ter Avest, Ron J Keizer, et al.
Cancer Research|October 15, 1996
Lack of glutathione conjugation of melphalan in the isolated in situ liver perfusion in humansA L Vahrmeijer, C A Snel, D P Steenvoorden, et al.
Investigational New Drugs|May 8, 2010
Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studiesElena Soto, Ron J Keizer, Iñaki F Trocóniz, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
British Journal of Cancer|May 2, 2000
Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liverA L Vahrmeijer, J H van Dierendonck, H J Keizer, et al.
Clinical Immunology (Orlando, Fla.)|December 27, 2011
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safetyJ J Hofstra, I Kleine Budde, E van Twuyver, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupO S Nielsen, I Judson, Q van Hoesel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupL Svancárová, J Y Blay, I R Judson, et al.
Pharmaceutics|November 26, 2022
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell TransplantationJordan T Brooks, Belen P Solans, Ying Lu, et al.
Pageof 21